Giftify, Inc. [NASDAQ: GIFT] saw a record 916% increase in category sales revenue following the launch of its GLP-1 savings campaign. Now, the company is building...
Giftify [NASDAQ: GIFT] is disrupting the GLP-1 market with a smart savings model providing consumers with discounted Ozempic and Wegovy. With the FDA closing the loophole...